Alzheimer’s Disease: Methods, Protocols, and Clinical Applications

Alzheimer's Disease: Methods, Protocols, and Clinical Applications provides a comprehensive, evidence-based exploration of the molecular, cellular, genetic, and clinical foundations of one of the world's most challenging neurodegenerative disorders. Bridging fundamental neuroscience with translational medicine, this authoritative volume examines the biology of amyloid precursor protein (APP), amyloid-β peptides, tau pathology, presenilin function, neuroinflammation, genetic susceptibility, and emerging therapeutic strategies. The book integrates established laboratory methodologies with modern experimental protocols used to investigate disease mechanisms, biomarker development, and therapeutic targets. Covering topics ranging from amyloid and tau biochemistry to transgenic animal models, protein phosphorylation, secretase biology, protein aggregation, and advanced cellular and molecular techniques, this text offers practical insights into both experimental design and clinical relevance. Each chapter presents scientifically grounded concepts alongside research applications that support the advancement of Alzheimer's disease investigation and drug discovery. Designed for neuroscientists, neurologists, physician-scientists, biomedical researchers, graduate students, and healthcare professionals, this book serves as both a methodological reference and a comprehensive guide to contemporary Alzheimer's disease research. Key Features - Comprehensive coverage of amyloid, tau, APP, and presenilin biology - Detailed experimental methods, protocols, and laboratory applications - Current perspectives on genetics, biomarkers, and disease mechanisms - Translational insights linking basic science to clinical practice - Evidence-based discussion of emerging therapeutic approaches >Combining scientific rigor with practical applicability, Alzheimer's Disease: Methods, Protocols, and Clinical Applications is an essential reference for understanding the mechanisms driving neurodegeneration and the ongoing pursuit of effective diagnostic and therapeutic strategies. Roger D. Centeno, PhD Neuroscientist, Alzheimer's Disease Researcher, and Clinical Translational Scientist

Pagina's: 363, Paperback, Independently published